PATENT CLAIM ANALYSIS

Application Number: 16148414
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["424", "186100"]

Abstract:
The present invention provides vaccines for treating or preventing a herpes simplex virus infection and methods of using and making the vaccine. Further provided are recombinant herpes simplex virus genomes, recombinant viruses, and immunogenic compositions.

Claim (Index 1):
A vaccine comprising a recombinant herpes simplex virus (HSV), wherein the recombinant HSV comprises a recombinant HSV genome comprising:\n (a) a modified UL53 gene comprising a deletion corresponding to the region of the UL53 gene that encodes amino acids 31-68 of wild-type gK; (b) a modified UL20 gene comprising a deletion corresponding to the region of the UL20 gene that encodes amino acids 4-22 of wild-type UL20 protein; and (c) a gene encoding a foreign antigen; wherein the recombinant HSV is capable of replication in a host cell and incapable of entry into axonal compartments of neurons; and

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.25806
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15310004', '15455495', '12598937', '15928377', '15015322']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7032989450937046
- 35 USC 102 Novelty (BERT): 0.7169466153643494
- Combined Prediction Score: 0.7046637121207691
- Mean Citation Score: 456.33795
- Max Citation Score: 796.5311
- Similarity Product: 744.9933954419793

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test